- Home
- ATRC vs BTT Comparison
ATRC vs BTT Comparison
Compare ATRC & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- BTT
- Stock Information
- Founded
- ATRC 2000
- BTT 2012
- Country
- ATRC United States
- BTT United Kingdom
- Employees
- ATRC N/A
- BTT N/A
- Industry
- ATRC Medical/Dental Instruments
- BTT Investment Managers
- Sector
- ATRC Health Care
- BTT Finance
- Exchange
- ATRC Nasdaq
- BTT Nasdaq
- Market Cap
- ATRC 1.6B
- BTT 1.4B
- IPO Year
- ATRC 2005
- BTT N/A
- Fundamental
- Price
- ATRC $31.13
- BTT $21.13
- Analyst Decision
- ATRC Strong Buy
- BTT
- Analyst Count
- ATRC 10
- BTT 0
- Target Price
- ATRC $48.50
- BTT N/A
- AVG Volume (30 Days)
- ATRC 639.5K
- BTT 151.1K
- Earning Date
- ATRC 04-30-2025
- BTT 01-01-0001
- Dividend Yield
- ATRC N/A
- BTT 2.95%
- EPS Growth
- ATRC N/A
- BTT N/A
- EPS
- ATRC N/A
- BTT N/A
- Revenue
- ATRC $465,307,000.00
- BTT N/A
- Revenue This Year
- ATRC $14.60
- BTT N/A
- Revenue Next Year
- ATRC $12.58
- BTT N/A
- P/E Ratio
- ATRC N/A
- BTT N/A
- Revenue Growth
- ATRC 16.55
- BTT N/A
- 52 Week Low
- ATRC $18.94
- BTT $18.90
- 52 Week High
- ATRC $43.11
- BTT $21.86
- Technical
- Relative Strength Index (RSI)
- ATRC 37.03
- BTT 53.26
- Support Level
- ATRC $31.02
- BTT $21.13
- Resistance Level
- ATRC $34.30
- BTT $21.35
- Average True Range (ATR)
- ATRC 1.75
- BTT 0.09
- MACD
- ATRC -0.03
- BTT 0.00
- Stochastic Oscillator
- ATRC 10.33
- BTT 77.59
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About BTT BlackRock Municipal 2030 Target Term Trust
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.